Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Naunyn-Schmiedeberg's Archives of Pharmacology • 2004 | View Paper
“However, sulpiride at a dose of 75 mg/kg × 2, coadministered with D-amphetamine (7.5 mg/kg × 4), potentiated the increase in extracellular dopamine and initially slightly enhanced D-amphetamine-induced stereotypy.”
“SummaryThe decrease in … single injection of (+)-amphetamine sulfate (9.2 mg/kg) to iprindole-… haloperidol (0.2 mg/kg), sulpiride (32 mg/kg), pimozide (2 mg/kg), chlorpromazine hydrochloride (3.5 mg/kg), fluphenazine 2-…/kg) but not by (−)-butaclamol hydrochloride (1 mg/kg) or clozapine (40 mg/kg).”
Pharmacology Biochemistry and Behavior • 1992 | View Paper
“The D-2 antagonists haloperidol and sulpiride decreased striatal neuronal activity in a dose-dependent manner and also effectively antagonized the effects of dexamphetamine.”
“Furthermore the stimulation of D1 receptors either by 2,3,4,5-tetrahydro,7,8-dihydroxy,1-phenyl,1-H,3-benzazepine or by D-amphetamine in the presence of S-sulpiride also enhanced the release of [3H]GABA.”
“Haloperidol, chlorpromazine and thioridazine blocked all ongoing behaviours while clozapine and sulpiride , regarded as causing less extrapyramidal side effects in the clinic, only antagonised the d-amphetamine induced locomotion.”
Pharmacology Biochemistry and Behavior • 1985 | View Paper
“Pimozide (4 mg/kg intraperitoneally) and L-sulpiride (40 mg/kg intraperitoneally) antagonized both the circling and increase in locomotor activity induced by quinine (0.1 mg/kg intra peritoneally) and D-amphetamine (4 mg/kg intraperitoneally) respectively.”